期刊文献+

还原型谷胱甘肽对体外循环期细胞因子IL-8和IL-6的影响

The effects of GSH on Cytokines IL-8,IL-6 during cardiopulmonary bypass
下载PDF
导出
摘要 目的观察还原型谷胱甘肽对体外循环(CPB)期间白细胞介素-8(IL-8)和白细胞介素-6(IL-6)的影响。方法选择30例施行心脏手术患者,随机分成实验组和对照组(每组15例)。实验组患者于手术开始时分别予还原型谷胱甘肽(35 mg/kg)溶于100 ml生理盐水静滴,对照组予生理盐水静滴。于CPB前(T1)、CPB 30 min(T2)、CPB停机(T3)、停机后2 h(T4)四个时点采血,采用放射免疫法测定两组血清中IL-8和IL-6的浓度。结果实验组IL-8、IL-6血清浓度较对照组降低,差异有统计学意义(P<0.05)。结论还原型谷胱甘肽能减少CPB期间IL-8和IL-6的释放,减轻全身炎性反应的程度。 Objective To investigate the effects of glutathione (GSH) on interleukin-8(IL-8) and interleukin-6 (IL-6) during cardiopulmonary bypass(CPB). Methods Thirty patients undergoing Cardiac surgery were randomly divided into GSH group and control group(15 in each group). In GSH group,intravenous drip of 100 ml of GSH(35 mg/kg)was given at the beginning of surgery. Respectively, while the control group was given 0.90/00 NaCl solution. Blood samples were taken before CPB,30min after CPB and 0h,2h after the end of CPB. The serum levels of IL-8 and IL-6 were measured by radioimmunoassay method in both groups. Results The serum levels of IL-8 and IL-6 in GSH group were significantly lower than that in control group( P 〈0.05). Conclusion The study shows that GSH could reduce the release of IL-8,IL-6 and inhibit systemic inflammatory response syndrome(SIRS) during CPB.
出处 《右江医学》 2010年第2期128-130,共3页 Chinese Youjiang Medical Journal
关键词 还原型谷胱甘肽 体外循环 炎性反应综合征 白介素-6 白介素-8 GSH cardiopulmonary bypass systemic inflammatory response syndrome interleukin-8 interleukin-6
  • 相关文献

参考文献14

  • 1Pintar T,Collard CD.The systemic inflammatory response to cardiopulmonary bypass[J].Anesthesiol Clin North America,2003,21:453-464.
  • 2Mcbride WT,Armstrong MA,Crockard AD,et al.Cytokine contrasting response between patients and isolated CPB circuits[J].Br J Anaesth,1995,75(6):724-733.
  • 3Mann DL.Congestive Heart Failure[M].Second Edition.Philadelphia:Lippincott Williams &Wilkins,2000:213-228.
  • 4李保春,崔若兰,梅长林,徐洪实,顾书华,邓翠珍.左旋肉碱对慢性肾衰腹透患者红细胞免疫功能的影响[J].第二军医大学学报,1999,20(7):420-421. 被引量:6
  • 5邓泽冰,徐金萍.体外循环的免疫反应[J].国外医学(麻醉学与复苏分册),1998,19(3):168-169. 被引量:2
  • 6李艳 ,黄从新 .重要炎性因子在冠心病病理过程中的作用[J].微循环学杂志,2004,14(1):47-49. 被引量:16
  • 7Gaudino M,Nasso G,Zamparelli R,et al.Inflammatory and fibrinoytic activation after coronary aetery bypass with extracorporeal circulation[J].Ital heart I Suppl,2002,3(6):646-651.
  • 8Brull DJ,Sanders J,Rumley A,et al.Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release[J].Heart,2002,87(3):252-255.
  • 9李Wan S,Desme JM,Barvais L,et al.Myocardium is a major Source of proinflammatory cytokines in patient undergoing cardiopulmonary bypass[J].J Thorac Cardiovase Surg,1996,112(3):806-811.
  • 10Kim PK,Deutschman CS.Inflammatory responses and mediators[J].Surg Clin North(Am),2000,80(3):885-894.

二级参考文献31

  • 1郭峰,黄盛东,赫丽,李淑德.红细胞在肿瘤免疫反应中的作用[J].中华微生物学和免疫学杂志,1995,15(3):183-187. 被引量:135
  • 2[1]Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340:115~126.
  • 3[2]Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J AM Coll Cardiol, 1998, 31:1 217~1 225.
  • 4[3]Schreyer SA, Vick CM,LeBoeuf RC. Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice. J Biol Chem, 2002, 277:12 364~12 368.
  • 5[4]Libby P, Warner SJ, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest,1998, 81:487~498.
  • 6[5]Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1receptor antagonist gene polymorphism in patients treated with coronary stenting. JACC, 2000, 36:2 168~2 173.
  • 7[6]Dewberry R, Holden H, Crossman D, et al. Interleukin-1 receptor antagonist expression in human endothelial cell and atherosclerosis. Arterioscler Thromb Vasc Biol, 2000, 20:2 394~2 400.
  • 8[7]Galea J, Armstrong JA, Gadsdon PA, et al. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol, 1996, 16:1 000~1 006.
  • 9[8]Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects-associations with obesity, insulin resistance and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Art Thromb Vasc Biol,1999,19:972~978.
  • 10[9]Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity,1997,6:1–20.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部